KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Recursion Pharmaceuticals (RXRX) Tax Rate: 2023-2025

  • Recursion Pharmaceuticals' Tax Rate fell 77.00% to 0.08% in Q1 2025 from the same period last year, while for Mar 2025 it was 0.09%, marking a year-over-year change of. This contributed to the annual value of 0.24% for FY2024, which is 98.00% down from last year.
  • Recursion Pharmaceuticals' Tax Rate amounted to 0.08% in Q1 2025, which was down 85.38% from 0.53% recorded in Q2 2024.
  • Recursion Pharmaceuticals' Tax Rate's 5-year high stood at 4.19% during Q4 2023, with a 5-year trough of 0.08% in Q1 2025.
  • Moreover, its 3-year median value for Tax Rate was 0.69% (2024), whereas its average is 1.41%.
  • Data for Recursion Pharmaceuticals' Tax Rate shows a maximum YoY crashed of 77bps (in 2025) over the last 5 years.
  • Over the past 3 years, Recursion Pharmaceuticals' Tax Rate (Quarterly) stood at 4.19% in 2023, then reached 0.53% in 2024, then plummeted by 77bps to 0.08% in 2025.
  • Its Tax Rate was 0.08% in Q1 2025, compared to 0.53% in Q2 2024 and 0.85% in Q1 2024.